Heart attack help: Program helps boost use of key therapies in hospitals

November 16, 2000

U-M program for doctors, nurses & patients boosts use of key proven therapies in heart attack victims

ANN ARBOR, MI - Heart experts know a lot about what heart attack patients need: aspirin and clot-busters in the emergency room; drugs like ACE inhibitors, beta blockers and cholesterol fighters; tests and procedures like angiography; and advice on diet, exercise and smoking.

But at many hospitals, there's a troubling gap between what experts say is best, and what patients actually get - mostly because there's been no consistent way to make sure the health care team gives every patient all the proven treatments recommended by national guidelines.

Now, University of Michigan Health System heart specialists are reporting success with a way to close that gap between knowledge and practice. Their solution: a program that targets doctors, nurses and patients alike with care standards, educational materials, reminders, and more.

This week, the U-M team published the encouraging results of their own test of the program, and presented early indications that such a strategy is producing similar results at 10 southeast Michigan hospitals. The paper was in the Nov. 13 Archives of Internal Medicine, and the presentation was at the American Heart Association's Scientific Sessions in New Orleans.

Among the findings: 98 percent of eligible U-M heart attack patients in the study got clot-busting drugs in the emergency room, most in the first hour. Over 94 percent were put on beta blockers, and 90 percent got ACE inhibitors - a jump from 65 percent and 45 percent, respectively, in 1995. The use of cholesterol-lowering drugs went from 38 percent to 67 percent. Ninety-four percent of smokers were counseled about stopping, and 96 percent got advice about diet.

Similar numbers, showing 90 percent or higher use for four of six key therapies, are emerging from preliminary findings at 10 other hospitals now using a similar program.

"The guidelines tell us that there are ten or so interventions that we know can truly help most heart attack patients," says Kim Eagle, M.D., interim chief of cardiology. "In the past four years, we have 'field tested' various strategies to optimize guideline-based treatment of heart attack. We've learned that using tools directed at patients, physicians, nurses and referring physicians provides for the most successful approach."

Eagle, lead author Rajendra Mehta, M.D., and their colleagues developed the program in the mid-90s. For the paper, they reviewed records for 497 patients treated at the U-M in a two-year period after the program began. Patients ranged in age from 20 to 99; 67 percent were male.

The initial results had been so positive that the American College of Cardiology, which helps issue and implement national heart attack guidelines, asked the U-M to help develop and test a similar program at other nearby hospitals of various types. That program is called the GAP (for Guidelines Applied in Practice) Initiative in Southeast Michigan, and involves not only hospitals but the Greater Detroit Area Health Council and the Michigan Peer Review Organization.

"We're delighted to now be working on the ACC's first GAP initiative," Eagle says. "Working with 10 hospitals in the greater Detroit area, we're striving to improve heart attack care throughout our region. The early experience is so encouraging that the ACC has invited us to take the program statewide, and is now considering a national initiative."

Showing that the program can work at non-university hospitals, at teaching and non-teaching institutions, and at community hospitals, is especially important to the project. The GAP project also includes hospitals with large and small numbers of heart attack patients, and hospitals whose patient populations are more predominantly non-white than the U-M's.

The early GAP results suggest the U-M program can work at all such places. The hospitals involved are: Bi-County, Harper, Henry Ford Wyandotte, Mt. Clemens General, Oakwood Dearborn, Oakwood Heritage, Providence, Sinai-Grace, St. Joseph's Mercy and St. John.

Says Mehta, "These results show that tools aimed at continuous education and reminder of caregivers regarding key aspects of patient care, along with education and empowerment of patients, are important elements for the success of any quality improvement initiative."

The U-M program's tools include: standing orders, pocket cards of medications and guidelines, a "clinical pathway" that guides doctors and nurses, classes for medical residents during their rotation in cardiology, a patient information form, stickers for the patient's chart, and a chart that tracks the hospital's performance. Before patients leave, doctors or selected nurses complete a checklist with them, giving a last chance for important prescriptions or lifestyle advice.

The list of key therapies includes: aspirin in the ER and at discharge, clot-busting drugs known as reperfusion therapy in the ER, measurements of blood cholesterol and the pumping capacity of the heart's left ventricle, catheterization or heart imaging studies in certain patients, selected angioplasty or bypass surgery, and use of beta blockers and ACE inhibitors. Smoking cessation counseling, diet counseling, and referral for outpatient rehabilitation are also key strategies. Not all patients need all these interventions, but the program ensures they get the ones they should.

Another key element is the patient education tool, a set of written and verbal materials that help the heart attack survivor understand what he or she must do to improve overall health and prognosis. This includes sticking with drug therapy, getting exercise and other rehabilitation after going home from the hospital, and the importance of not smoking.

The new study of U-M patients gave the patient-education information to half the patients. By discharge, those patients were more likely to have gotten drug therapy, and smoking cessation and rehabilitation advice. Now, the team is studying how well patients did in staying with those important treatments up to 18 months post discharge, and provided its faculty, nurses and doctors-in-training with an annual "report card" that emphasizes opportunities to improve further.

University of Michigan Health System

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.